Enviomycin
Systematic (IUPAC) name | |
---|---|
3,6-diamino-N-[(3R,6Z)-3-(2-amino-3,4,5,6-tetrahydropyrimidin-4-yl)-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]-4-hydroxyhexanamide | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
| |
IM | |
Identifiers | |
33103-22-9 | |
None | |
PubChem | CID 3032903 |
DrugBank | DB08993 |
ChemSpider | 16736480 |
UNII | XU299C23A2 |
KEGG | D07897 |
Chemical data | |
Formula | C25H43N13O10 |
685.69 g/mol | |
SMILES
| |
| |
(what is this?) (verify) |
Enviomycin (INN, also called tuberactinomycin N) is an antibiotic drug, isolated from Streptomyces griseoverticillatus var. tuberacticus.[1] It is used in the treatment of tuberculosis.[2]
References
- ↑ Jinnosuke Abe et al. Antibiotic Tuberactinomycin-N and process for production thereof. US patent 3892732
- ↑ Selvakumar, N; Kumar, V; Acharyulu, GS; Rehman, F; Paramasivan, CN; Prabhakar, R (1992). "Susceptibility of south Indian strains of Mycobacterium tuberculosis to tuberactinomycin". The Indian journal of medical research 95: 101–4. PMID 1506058.